subscales

Related by string. Subscale . subscale * * subscale scores . Scale cognitive subscale . function subscales . function subscale . Scale Cognitive Subscale . pain subscale *

Related by context. All words. (Click for frequent words.) 79 subscale scores 73 subscores 73 PANSS 73 EQ 5D 73 Montgomery Åsberg Depression 72 QoL 70 HRQL 70 Brief Psychiatric 70 Health Assessment Questionnaire 69 HRQOL 68 symptom severity 68 HRQoL 68 HAM D# 68 HADS 67 subscore 67 BPRS 67 psychometric properties 67 WOMAC pain 67 WOMAC 66 Symptom Checklist 66 PSQI 66 Rating Scale MADRS 66 NIH CPSI 66 point Likert scale 66 Negative Syndrome 66 Visual Analog Scale 65 Scale PANSS 65 Physical Component 65 IBDQ 65 MADRS 65 Montgomery Asberg Depression 65 Cronbach alpha 65 Neuropsychiatric Inventory 65 BMI z 65 UPDRS 65 Global Impression CGI 65 somatic symptoms 65 HDRS 65 Outcomes Study 65 HAMD 64 Rating Scale 64 Alzheimer Disease Assessment 64 subscale 64 SGRQ 64 subtests 64 MMSE score 64 YMRS 64 Global Impression 63 interrater reliability 63 Functional Assessment 63 covariate 63 Rating Scale BPRS 63 Visual Analog 63 Oswestry Disability Index 63 ANOVA 63 intraclass correlation coefficients 63 premorbid 63 Depression Rating Scale 63 IIEF 63 Depression Inventory 63 ADAS Cog 63 VFQ 62 ADAS cog 62 retest reliability 62 cognitive affective 62 depressive symptom 62 alexithymia 62 HAQ DI 62 Mental Component 62 EORTC QLQ C# 62 convergent validity 62 Depression Scale 62 Child Behavior Checklist 62 Hamilton Rating Scale 62 MADRS score 62 Disease Activity 62 Clinician Administered PTSD 62 multivariate analyzes 62 psychosocial functioning 62 Fibromyalgia Impact Questionnaire 62 MMSE 61 cognitive domains 61 Distress Scale 61 Primary endpoints 61 Secondary efficacy endpoints 61 Incontinence Impact Questionnaire 61 Main Outcome Measures 61 pain subscale 61 QIDS SR 61 DAS# [002] 61 Score DAS 61 p = .# [002] 61 International Prostate Symptom 61 comorbid 61 Visual Analogue Scale VAS 61 bivariate analyzes 61 Depressive symptoms 61 univariate analyzes 61 Cronbach 61 affective disorders 61 depressive symptomatology 61 Index CDAI 61 HAM D 61 Secondary endpoints 61 euthymic 60 Geriatric Depression 60 univariate analysis 60 ADCS ADL 60 Secondary endpoints included 60 CORE OM 60 CI -#.# 60 logistic regression 60 apnea hypopnea index 60 psychosocial variables 60 IRLS 60 confidence intervals CIs 60 P = .# 60 Epworth Sleepiness Scale 60 SF #v# 60 multivariable analysis 60 CDAI 60 Univariate analysis 60 Scale Cognitive Subscale 60 State Examination MMSE 60 Comorbidity 60 emotional lability 60 bivariate 60 Score DAS# 60 depressive symptoms 60 SDQ 60 Abnormal Involuntary Movement 60 syndromal 60 Pearson correlation coefficient 60 Y BOCS 60 Likert 60 WOMAC scores 60 UPDRS motor 60 Seattle Angina Questionnaire 60 symptomatology 59 interobserver 59 preoperatively 59 correlation coefficients 59 Likert scale 59 MetS 59 Symptom severity 59 Regression analyzes 59 psychopathological symptoms 59 Neuropsychiatric Inventory NPI 59 Glasgow Coma Scale 59 neurocognitive function 59 poststroke 59 Assessment Scale 59 posttreatment 59 covariates 59 NIHSS 59 logistic regression model 59 MMSE scores 59 tertiles 59 Subscale 59 Preoperatively 59 FACIT 59 PANSS scores 59 logistic regression analyzes 59 comorbid anxiety 59 HOMA IR 59 = #.#-#.# 59 mRS 59 clinically meaningful improvements 59 Crohn Disease Activity 59 Unified Parkinson Disease 59 Severity Index 59 psychiatric morbidity 59 PANSS total 59 Female Sexual Function 59 comorbidity 59 dyspnoea 59 Inventory BPI 59 Logistic regression 59 Pain Intensity 58 Beck Anxiety Inventory 58 multiple logistic regression 58 erythrocyte sedimentation rate 58 APACHE II 58 adenotonsillectomy 58 odds ratios ORs 58 Pain Rating Scale 58 State Trait Anxiety 58 daytime somnolence 58 nasal symptom 58 exploratory endpoints 58 Multivariate analysis 58 sociodemographic characteristics 58 Rating Scale UPDRS 58 % CI #.#-#.# [006] 58 Mania Rating Scale 58 regression analyzes 58 psychoeducation 58 actigraphy 58 Visual Analogue Scale 58 univariate 58 Index HAQ DI 58 IPSS 58 neurocognitive functioning 58 Neuroticism 58 nonobese 58 subjective sleepiness 58 neuropsychological 58 Symptom Severity 58 euthymic patients 58 Questionnaire 58 chi squared 58 affective psychosis 58 McGill Pain Questionnaire 58 clinically meaningful improvement 58 psychiatric comorbidity 58 KOOS 58 Status Scale EDSS 58 Satisfaction Questionnaire 58 Edinburgh Postnatal Depression 58 Negative Symptoms 58 Hopkins Symptom Checklist 58 suicide attempters 58 metabolic parameters 58 Brief Pain 58 p = #.# [002] 57 Index FSFI 57 posttest 57 erection hardness 57 ANCOVA 57 Wechsler Adult 57 nondepressed 57 nausea photophobia 57 Sociodemographic 57 hyperarousal 57 WCST 57 df = 57 LUTS 57 Injury Severity Score 57 Likert type 57 autonomic dysfunction 57 variance ANOVA 57 logistic regression analysis 57 Global Impression Severity 57 NYHA functional class 57 symptom checklist 57 HAQ 57 DAS# scores 57 tertile 57 Score IPSS 57 NPRS 57 predictive validity 57 PHQ 9 57 Heritability 57 Dyspnea 57 r = 57 Univariate 57 somatization disorder 57 preoperative 57 IKDC 57 hyperactivity inattention 57 GERD symptom 56 salivary cortisol 56 Psoriasis Area 56 Score TOS 56 SELENA SLEDAI 56 sd = 56 Depression Inventory BDI 56 psychiatric comorbidities 56 vasomotor 56 Mini Mental 56 ADHD Rating Scale 56 ADHD RS 56 achieved statistical significance 56 DLQI 56 ADCS CGIC 56 comorbid depression 56 function subscale 56 NIS LL 56 sociodemographic variables 56 Main Outcome Measure 56 urodynamic parameters 56 pain catastrophizing 56 F FDG PET 56 multivariate Cox 56 #q# deletion syndrome 56 HbA 1c 56 PCWP 56 Subgroup analyzes 56 multivariable analyzes 56 somatization 56 conditional logistic regression 56 DAS# CRP 56 56 T2DM 56 non menstrual pelvic 56 generalized estimating 56 liver histology 56 intraclass correlation coefficient 56 neuropsychological assessment 56 ASIA Impairment 56 QOL 56 β = 56 Symptom 56 Erectile Function 56 methacholine challenge 56 logistic regression models 56 meta analytic 56 affective psychoses 56 semiquantitative 56 Depressive Symptoms 56 FACIT Fatigue 56 p = #.# [004] 56 subtest 56 Kruskal Wallis test 56 nonparametric 56 confidence interval CI 56 dyspnea 56 Urogenital Distress Inventory 56 Ocular Surface Disease 55 logistic regressions 55 overnight polysomnography 55 Key secondary endpoints 55 somatoform disorders 55 Logistic regression analysis 55 multivariate logistic regression 55 serologically active patients 55 Secondary endpoints include 55 EDSS 55 Cognitive Abilities Test 55 endometrial thickness 55 quartiles 55 Kaplan Meier curves 55 clinicopathological 55 Meta analyzes 55 Difficulties Questionnaire 55 preoperative PSA 55 semistructured interview 55 EDSS score 55 intraobserver 55 Structured Clinical 55 plasma folate 55 Wechsler Memory 55 Bonferroni correction 55 Interrater reliability 55 Maslach Burnout Inventory 55 multivariable adjusted 55 Expanded Disability Status 55 Predictors 55 Subjective 55 State Exam MMSE 55 hippocampal volume 55 % CI #.#-#.# [003] 55 interobserver reliability 55 Scale Revised 55 WAIS III 55 verbal fluency 55 Numeric Rating Scale 55 Descriptive statistics 55 carotid IMT 55 nighttime awakenings 55 abdominal pain abdominal discomfort 55 multivariate analysis 55 hypersomnia 55 enthesitis 55 fasting insulin 55 meta regression 55 unpaired t 55 â ‰ ¥ 55 daytime alertness 55 hippocampal volumes 55 LVEF 55 LV ejection fraction 55 highest tertile 55 Acute Physiology 55 ALSFRS R 55 sociodemographic 55 schizophrenia schizoaffective disorder 55 r2 = 55 DSM IV TR 55 % Confidence Interval 55 nerve conduction velocity 55 non affective psychosis 55 prognostic factors 55 extrapyramidal symptoms 55 psychiatric outpatients 55 left ventricular diastolic 55 mTSS 55 secondary endpoints 55 PERMP 55 interrater 55 % CI #.#-#.# [007] 55 IIQ 55 Exclusion criteria 55 schizophreniform disorder 55 untreated psychosis 54 MSLT 54 chronicity 54 diastolic pressures 54 Chronic Illness Therapy 54 somatic complaints 54 -#.# ± [002] 54 Visual acuity 54 postoperatively 54 psychomotor 54 TNSS 54 abdominal circumference 54 Severity Index PASI 54 dysthymia 54 et al #b 54 Rosenberg Self Esteem 54 Diagnostic Interview 54 tibiofemoral 54 Neuropsychological 54 postinjury 54 primary aldosteronism 54 CSBM 54 Pearson correlation coefficients 54 pharmacokinetic parameters 54 dichotomized 54 Mean Symptom Complex 54 CNS LS 54 Anxiety Scale 54 Kellgren Lawrence 54 hemodynamic measurements 54 p = 54 mg BID dose 54 Erectile Function IIEF 54 biopsy Gleason 54 interpersonal psychotherapy 54 EPDS 54 comorbid psychiatric disorders 54 lipid parameters 54 Suicidal ideation 54 rheumatoid factor 54 STAI 54 Outcome Measures 54 postintervention 54 postural sway 54 Hamilton Anxiety Scale 54 CI = 54 bivariate analysis 54 lymphocyte count 54 BPS IC 54 Scale cognitive subscale 54 hypomanic symptoms 54 Conflict Tactics 54 somatic symptom 54 Bonferroni 54 Assessment Questionnaire 54 incontinence episodes 54 DSM IV criteria 54 BPH symptom 54 baseline HbA1c 54 % CI #.#-#.# [005] 54 TEAEs 54 echocardiographic parameters 54 rs# [004] 54 subsyndromal 54 IRLS score 54 comorbidities 54 coronary stenosis 54 ± SD 54 antidepressant efficacy 54 fractional anisotropy 54 Clinical Dementia 54 DSM IV diagnoses 54 callous unemotional traits 54 NNT = 54 Scale EDSS 54 hip BMD 54 alanine aminotransferase ALT 54 anthropometric measures 54 p = #.# [003] 54 akathisia 53 P ≤ 53 CI #.#-#.# [001] 53 covariance 53 PLMs 53 Depression Scale HADS 53 secondary endpoint 53 Postoperative 53 mm Hg diastolic 53 Treatment Outcome 53 albumin excretion rate 53 randomized controlled trials RCTs 53 cardiac autonomic 53 Hemodynamic 53 Poisson regression 53 schizotypal 53 explanatory variables 53 multiple linear regression 53 mRNA expression 53 prespecified secondary 53 posttransplant 53 Psychodynamic 53 HRCT 53 Perceived Stress Scale 53 multivariable Cox 53 Multivariable 53 decrements 53 Generalized Anxiety Disorder 53 psychophysiological 53 femoral neck BMD 53 Conscientiousness 53 statistically significant improvement 53 Index WOMAC 53 depression irritability 53 Severity MSCS score 53 % CI #.#-#.# [008] 53 endoscopic remission 53 WOMAC TM 53 multivariable logistic regression 53 postop 53 secondary efficacy endpoints 53 ‰ ¥ 53 polyarticular 53 episodic migraine 53 comorbid conditions 53 ß = 53 daytime sleepiness 53 Stroke Scale 53 paresthesias 53 PANSS Positive 53 secondary efficacy endpoint 53 desvenlafaxine succinate 53 REYATAZ r arm 53 SSRI SNRI 53 GH deficiency 53 ejaculatory function 53 hypochondriasis 53 rhinoconjunctivitis 53 CDAI score 53 Charlson Comorbidity Index 53 KCCQ 53 SSRI citalopram 53 hemoglobin A1c levels 53 amygdala reactivity 53 Comorbidities 53 nonsignificant 53 HbA1C levels 53 CCyR 53 Likert scales 53 electrophysiologic 53 Wilcoxon rank sum 53 PsA 53 psychopathology 53 prevalences 53 Functional Outcomes 53 Depressive Symptomatology 53 QRS duration 53 laterality 53 composite endpoint 53 apolipoprotein B 53 neuropsychological tests 53 CIs 53 multivariable 53 subclinical atherosclerosis 53 dysphoric 53 analgesic efficacy 53 neurocognition 53 autistic traits 53 clinicopathological features 53 CONCERTA ® 53 neuropsychological functioning 53 electroencephalographic 53 Ashworth Scale 53 subthreshold depression 53 rCBF 53 Symptom Scale 53 Stroke Scale NIHSS 53 prospectively defined 53 BILAG 53 clinicopathologic 53 detrusor 53 CPAP adherence 52 Subgroups 52 CLBP 52 creatinine ratio 52 Preoperative 52 CSBMs 52 Neurocognitive 52 albumin excretion 52 function subscales 52 subsyndromal depression 52 extensive metabolizers 52 neurocognitive 52 phonophobia 52 CIBIC plus 52 CC genotype 52 et al #a 52 dyspareunia 52 nondiabetic patients 52 maximal treadmill 52 Postoperatively 52 binary logistic regression 52 MCID 52 fructosamine 52 FOLPI 52 confidence interval #.#-#.# 52 categorical variables 52 apnea hypopnea 52 plasma leptin 52 parkinsonian 52 linear regression analysis 52 spirometric 52 RECIST Response Evaluation Criteria 52 multivariate regression analysis 52 nasal obstruction 52 internalizing behaviors 52 bronchial hyperresponsiveness 52 polysomnogram 52 oxycodone CR 52 NIHSS score 52 CIBIC + 52 HbA 1c levels 52 attain statistical significance 52 demographic variables 52 macroalbuminuria 52 Baseline characteristics 52 URTI 52 inattention hyperactivity 52 leukocyte counts 52 BMI waist circumference 52 biochemical recurrence 52 immunostaining 52 INVEGA ® 52 aspartate aminotransferase AST 52 methotrexate monotherapy 52 placebo p = 52 thyrotropin levels 52 avoidant personality disorder 52 elevated ALT 52 urinary N telopeptide 52 serum cortisol 52 neurologic impairment 52 psychomotor speed 52 OSDI 52 lipid profiles 52 statistically nonsignificant 52 Multiple linear regression 52 detrusor overactivity 52 APOE genotype 52 pharmacodynamic PD 52 observable behaviors 52 Sleep Disturbance 52 bulimia nervosa 52 ACR Pedi 52 p = .# [001] 52 n = 52 elevated creatinine 52 sociodemographic factors 52 psychosocial 52 plasma glucose concentration 52 intima media thickness 52 lability 52 hypoglycemic events 52 comorbid disorders 52 adjunctive ABILIFY 52 % CI #.#-#.# [004] 52 CFQ R 52 Apgar scores 52 fasting plasma 52 substance induced psychosis 52 urodynamic 52 adjunctive placebo 52 lowest tertile 52 Personality disorders 52 primary efficacy endpoints 52 extrapyramidal side 52 neurobehavioral 52 pharmacokinetics PK 52 ALS Functional 52 Response Evaluation Criteria 52 umol L 52 CT perfusion 52 spontaneous bowel movements 52 male Wistar rats 52 DSM IV 52 interpersonal psychotherapy IPT 52 intact parathyroid hormone 52 adiponectin concentrations 52 MDRD 52 immunohistochemical staining 52 amnestic MCI 52 OGTT 52 psychodynamic psychotherapy 52 Multivariate logistic regression 51 CRp 51 sensory gating 51 Efficacy endpoints 51 CHADS2 51 orthostatic 51 somatoform disorder 51 death reinfarction 51 allele frequencies 51 tic disorders 51 serum IGF 51 somatosensory evoked potentials 51 neuroimaging studies 51 Logistic regression analyzes 51 EEG recordings 51 Severity CGI S 51 fasting plasma glucose FPG 51 SGAs 51 Multivariate analyzes 51 Anxiety Rating Scale 51 Cognitive behavioral 51 visuospatial 51 AUCs 51 DSM IV diagnosis 51 voiding dysfunction 51 genotypic resistance 51 colorectal adenoma 51 Symptom Score 51 HbA 1C 51 % CI #.#-#.# [002] 51 CHADS 51 neurosensory 51 plasma pharmacokinetics 51 timepoints 51 tolterodine ER 51 Histologic 51 cardiometabolic risk 51 x ULN 51 Agreeableness 51 Histopathologic 51 Scale 51 inflammatory biomarkers 51 undetectable HBV DNA 51 neurobehavioural 51 CRQ 51 progression TTP 51 nonpsychotic 51 Rating Scale IRLS 51 RCTs 51 mean ± SEM 51 Insomnia Severity Index 51 placebo p 51 postprocedure 51 serum PTH 51 oxygen desaturation 51 neuropsychological assessments 51 DSM IV Axis 51 Scale EDSS score 51 mesalamine granules 51 ACR# ACR# 51 RLS symptoms 51 glycated hemoglobin 51 NYHA 51 urine albumin 51 Functioning GAF 51 PLMS 51 akinesia 51 internalizing disorders 51 comorbid diagnoses 51 Kaplan Meier survival 51 amisulpride 51 Kruskal Wallis 51 neurophysiologic 51 mIU L 51 neuropsychiatric symptoms 51 plain radiographs 51 eNO 51 self directedness 51 euthyroid 51 arterial oxygen saturation 51 FSFI 51 comorbid psychiatric 51 neuroleptic 51 Insulin sensitivity 51 postoperative complication 51 OAB symptoms 51 linear regression analyzes 51 Cockcroft Gault 51 Functioning Scale 51 placebo fluoxetine 51 μmol L 51 plasma adiponectin 51 Subgroup analysis 51 patients evaluable 51 chest radiographs 51 alanine aminotransferase 51 cognitive functioning 51 myocardial viability 51 tic severity 51 Scale CNS 51 Lower Limb 51 SGPT 51 homozygotes 51 CYP#D# inhibitor 51 externalizing behaviors 51 handgrip strength 51 perioperative complications 51 PSA nadir 51 left ventricular systolic 51 histologic 51 Impulsivity 51 antidepressant monotherapy 51 Charlson comorbidity index 51 Prognostic 51 CIMZIA TM certolizumab pegol 51 tryptophan depletion 51 SGOT 51 brachial artery flow 51 dysuria 51 Anthropometric 51 parietal cortices 51 postoperative AF 51 Irritability 51 allostatic load 51 pharmacodynamic endpoints 51 Lumbar spine 51 diastolic BP 51 haematologic 51 histopathologic 51 hemoglobin Hb 51 docetaxel pretreated 51 clomipramine 51 Socio demographic 51 diabetes mellitus DM 51 demonstrated clinically meaningful 51 psychoeducational 51 Comorbid 51 prognostic significance 51 LDL HDL 51 parkinsonism 50 nonoperative treatment 50 EBMT criteria 50 acute subacute 50 clinically meaningful reductions 50 Kaplan Meier analysis 50 histologic findings 50 neurocognitive deficits 50 magnetic resonance spectroscopic imaging 50 = .# 50 Clinically meaningful 50 UGT#A# * 50 Neuropsychological Status 50 CT urography 50 Psychomotor 50 Mood disorders 50 preintervention 50 stepwise logistic regression 50 mcg QD 50 fasting plasma glucose 50 left ventricular LV 50 extraversion 50 #OHD 50 fluoxetine Prozac 50 EuroSCORE 50 submaximal 50 virological response 50 LS BMD 50 gene polymorphisms 50 tipranavir r 50 hemodynamic parameters 50 serum concentrations 50 Multivariate analysis revealed 50 psychiatric diagnoses 50 mania hypomania 50 serum BDNF 50 Fasting plasma glucose 50 hepatic lesions 50 UPDRS Part III 50 nonfatal MI 50 NMES 50 CTEPH 50 POAG 50 SRBD 50 FEV ^ sub 50 treatment emergent AEs 50 mediated dilation 50 nonvertebral fracture 50 ejaculatory control 50 mcg Albuferon 50 CD# expression [002] 50 abdominal adiposity 50 ETDRS 50 extroversion agreeableness 50 prespecified 50 Anxiety Depression 50 statistically significant p = 50 RECIST criteria 50 morphometric vertebral fractures 50 systolic BP 50 Thrombolysis 50 HBeAg negative patients 50 tumor histology 50 TT genotype 50 urinary symptoms 50 atypical neuroleptics 50 receiving VICTRELIS 50 Depression Anxiety 50 visceral adiposity 50 Interpersonal psychotherapy 50 nontraumatic 50 fluoxetine paroxetine 50 virologic response 50 Prognostic Index 50 Multiple logistic regression 50 probands 50 CIN2 + 50 HbA1c levels 50 Severity Scale 50 sensitivity specificity 50 Skin sterol 50 posttraumatic 50 posterior cingulate 50 distal radial fractures 50 lymphovascular invasion 50 serum prostate 50 partial remissions 50 overactive bladder symptoms 50 aripiprazole 50 cardio respiratory fitness 50 generalized anxiety disorder GAD 50 solifenacin 50 Posttraumatic stress disorder 50 transaminase elevations 50 Major Depressive Disorder 50 psychopathological 50 histological subtype 50 GH deficient 50 cortical atrophy 50 hyperintensity 50 periprocedural MI 50 COMT genotype 50 serum ALT 50 male Sprague Dawley 50 oncologic outcomes 50 lopinavir r arm 50 System IPSS 50 Bayley Scales 50 neuromotor 50 QD dosing 50 Pharmacologic 50 OSAHS 50 #F FDG PET 50 demonstrated statistically significant 50 axial length 50 inotropic 50 glycosylated hemoglobin HbA1c 50 nasal polyposis 50 SCr 50 Epidemiologic Studies Depression 50 dosage regimens 50 seminal vesicle invasion 50 serum leptin 50 ERalpha 50 ALT elevations 50 headache abdominal pain 50 exhaled nitric oxide 50 normotensive 50 lesional 50 Digit Span 50 cytogenetic abnormalities 50 hypogonadal 50 plasma cortisol 50 Subtypes 50 clinical meaningfulness 50 hsCRP 50 Mammographic 50 TMC# r 50 plasma lipids 50 radiographic findings 50 symptom exacerbation 50 immunoreactivity 50 externalizing disorders 50 systolic function 50 ADLs 50 #.# df = 50 glycosylated hemoglobin 50 corticosteroid dose 50 Cardiorespiratory fitness 50 colesevelam 50 anhedonia 50 nonfasting 50 sUA 50 symptomatic VTE 50 prospective longitudinal 50 unipolar depression 50 mU L 50 psychodynamic therapy 50 convergence insufficiency 50 CR CRu 50 aspartate aminotransferase 50 neuroanatomical 50 lumbar spine BMD 50 nocturnal enuresis 50 5 HTTLPR genotype 50 AUC0 50 peak VO2 50 methodologic 50 Adult ADHD 50 Cystatin C 50 pharmacodynamic parameters 50 dyads 50 laboratory abnormalities 50 serum ferritin

Back to home page